Bringing clinically-validated AI to Intensive Care

At AlgoDx, the premise underlying all our research is the final product’s reliability. Our research methods are based on gold standards used in medical device and pharmaceutical development. We use a scientific, evidence-based approach with regulatory requirements in mind.

NAVOY® Product Suite

The NAVOY® portfolio includes machine learning algorithms specifically designed for Intensive Care. Developed for conditions with high unmet medical need, these algorithms are designed to generate robust clinical evidence for product claims, covering clinical and health-economic benefits as well as potential risks.

AlgoDx Clinical Pipeline as of November 2021
               
Pre-Clinical R&D
Regulatory Clearance
Clinical Validation
PMCF*
NAVOY® Sepsis
                                                    
NAVOY® Acute Kidney Injury
 
                                                                         
Undisclosed Therapeutic Indication                                      
Undisclosed Therapeutic Indication                                     
Undisclosed Therapeutic Indication                                      
Ongoing
Complete

* Post-Marketing Clinical Follow-up
 

Clinical Trials – AlgoDx sponsored clinical research

For more information on our ongoing clinical projects, visit clinicaltrials.gov

ExPRESS

Early Prediction of Sepsis in Hospitalized Patients Using a Machine Learning Algorithm, a Randomized Clinical Validation Trial.

Protocol number: NCT04570618

GENIUS

Integration and Evaluation of a Machine Learning Algorithm for Sepsis Prediction in an Electronic Health Record System a Prospective Observational Study.

Protocol number: NCT05095220

AlgoDx Products in the Clinical Workflow